- Home
- RLAY vs XFLT Comparison
RLAY vs XFLT Comparison
Compare RLAY & XFLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- XFLT
- Stock Information
- Founded
- RLAY 2015
- XFLT 2017
- Country
- RLAY United States
- XFLT United States
- Employees
- RLAY N/A
- XFLT N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- XFLT Investment Managers
- Sector
- RLAY Health Care
- XFLT Finance
- Exchange
- RLAY Nasdaq
- XFLT Nasdaq
- Market Cap
- RLAY 490.3M
- XFLT 439.2M
- IPO Year
- RLAY 2020
- XFLT N/A
- Fundamental
- Price
- RLAY $3.18
- XFLT $5.49
- Analyst Decision
- RLAY Strong Buy
- XFLT
- Analyst Count
- RLAY 11
- XFLT 0
- Target Price
- RLAY $18.40
- XFLT N/A
- AVG Volume (30 Days)
- RLAY 1.5M
- XFLT 336.2K
- Earning Date
- RLAY 08-05-2025
- XFLT 01-01-0001
- Dividend Yield
- RLAY N/A
- XFLT 14.17%
- EPS Growth
- RLAY N/A
- XFLT N/A
- EPS
- RLAY N/A
- XFLT N/A
- Revenue
- RLAY $7,679,000.00
- XFLT N/A
- Revenue This Year
- RLAY $14.31
- XFLT N/A
- Revenue Next Year
- RLAY N/A
- XFLT N/A
- P/E Ratio
- RLAY N/A
- XFLT N/A
- Revenue Growth
- RLAY N/A
- XFLT N/A
- 52 Week Low
- RLAY $1.78
- XFLT $6.01
- 52 Week High
- RLAY $10.72
- XFLT $7.76
- Technical
- Relative Strength Index (RSI)
- RLAY 55.48
- XFLT 30.97
- Support Level
- RLAY $2.98
- XFLT $5.71
- Resistance Level
- RLAY $3.48
- XFLT $5.78
- Average True Range (ATR)
- RLAY 0.25
- XFLT 0.07
- MACD
- RLAY -0.00
- XFLT -0.03
- Stochastic Oscillator
- RLAY 58.45
- XFLT 9.76
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About XFLT XAI Octagon Floating Rate & Alternative Income Term Trust of Beneficial Interest
XAI Octagon Floating Rate & Alternative Income Trust is a diversified, closed-end management investment company which invests in a dynamically managed portfolio of floating-rate credit instruments and other structured credit investments within the private markets. The Trust's investment objective is to seek attractive total return with an emphasis on income generation across multiple stages of the credit cycle.